Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 15:8:20552076221119327.
doi: 10.1177/20552076221119327. eCollection 2022 Jan-Dec.

Tele-yoga for the management of Parkinson disease: A safety and feasibility trial

Affiliations

Tele-yoga for the management of Parkinson disease: A safety and feasibility trial

Aurora M James-Palmer et al. Digit Health. .

Abstract

Objectives: Despite current standard treatments, persons with Parkinson disease (PD) still experience motor and non-motor symptoms that impact daily function and quality of life, warranting the investigation of additional interventions. Holistic complementary interventions such as yoga have been shown to be beneficial for persons with PD. However, there are multiple barriers to in-person interventions such as transportation difficulties and disease-related mobility impairments which may be mitigated by digital health applications. Therefore, this study's purpose was to assess the safety and feasibility of a synchronous tele-yoga intervention for persons with PD.

Methods: Sixteen participants were enrolled in a single group safety and feasibility trial. The entire study was conducted remotely and consisted of a baseline assessment followed by a six-week waiting period, then a second assessment, a six-week tele-yoga intervention period, a post-intervention assessment, a six-week follow-up period, and lastly a follow-up assessment. During the tele-yoga period, participants completed two one-on-one 30-minute tele-yoga sessions weekly for a total of 12 sessions. Primary outcomes included adverse events, adherence, technological challenges, and usability. Secondary outcomes included enjoyment and clinically relevant outcome measures assessing both motor and non-motor symptoms.

Results: No severe adverse events were attributed to the intervention. Retention was 87.5%, assessment session adherence was 100%, and intervention session adherence was 97%. Technological challenges did not impact feasibility. The intervention was usable and enjoyable. While this study was not powered or designed to assess the efficacy of the intervention, preliminary improvements were shown for some of the clinically relevant outcome measures.

Conclusions: Overall, this study showed that the implementation of a synchronous one-on-one tele-yoga intervention was safe, feasible, usable, and enjoyable for persons with PD. Randomized control trials investigating its efficacy should be initiated. The study was registered with ClinicalTrials.gov (NCT04240899, https://clinicaltrials.gov/ct2/show/NCT04240899).

Keywords: Telerehabilitation; complementary therapies; movement disorders; videoconferencing; yoga.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Illustration of the study timeline. *After reviewing and singing the informed consent participants completed the Parkinson’s Anxiety Scale (PAS) to confirm baseline symptoms of anxiety. If participants did not reach the eligibility score (≥ 14), responses were destroyed, and participation ceased. If eligibility scores were met participants completed T0 and continued study participation (see Figure 3).
Figure 2.
Figure 2.
The breathing exercises, postures, and relaxation exercises taught in the yoga intervention period.
Figure 3.
Figure 3.
The recruitment and enrollment CONSORT chart.

Similar articles

Cited by

References

    1. Dorsey ER, Constantinescu R, Thompson JP, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurology 2007; 68: 384–386. - PubMed
    1. Tarakad A, Jankovic J. Diagnosis and management of Parkinson’s disease. Semin Neurol 2017; 37: 118–126. - PubMed
    1. Capriotti T, Terzakis K. Parkinson Disease. Home Heal Now 2016; 34: 300–307. - PubMed
    1. Gulunay A, Cakmakli GY, Yon MI, et al. Frequency of non-motor symptoms and their impact on the quality of life in patients with Parkinson’s disease: a prospective descriptive case series. Psychogeriatrics. Epub ahead of print 2019. DOI: 10.1111/psyg.12489 - DOI - PubMed
    1. Pfeiffer RF. Non-motor symptoms in Parkinson’s disease. Park Relat Disord 2016; 22: S119–S122. - PubMed

Associated data

LinkOut - more resources